written on 12.03.2014

With Big 5, Bayer aims for 8% annual pharma growth through 2016


The CEO of the German drugmaker is pinning some numbers on the medium term; the Big 5 will help Bayer aim for an average of 8% annual growth in its pharma unit through 2016, Marijn Dekkers said Wednesday.